Postmarket Surveillance Plans May Be Less Burdensome Under Proposed Rule

Medical device manufacturers would be able to satisfy postmarket surveillance orders using secondary data collection methods or literature reviews, provided their proposed method answered the surveillance question posed by FDA, under an Aug. 29 proposed rule.